These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2459015)

  • 21. A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia A.
    Bolon-Larger M; Chamouard V; Bressolle F; Boulieu R
    Ther Drug Monit; 2007 Feb; 29(1):20-6. PubMed ID: 17304146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of thiamylal in cats.
    Wertz EM; Benson GJ; Thurmon JC; Tranquilli WJ; Davis LE; Koritz GD
    Am J Vet Res; 1988 Jul; 49(7):1079-83. PubMed ID: 3421532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of intranasal and intratracheal pentoxifylline in rabbits.
    Adcock KG; Kyle PB; Deaton JS; Olivier JH; Hogan SM
    Pharmacotherapy; 2007 Feb; 27(2):200-6. PubMed ID: 17253910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enantioselective pharmacokinetics of racemic carprofen in New Zealand white rabbits.
    Hawkins MG; Taylor IT; Craigmill AL; Tell LA
    J Vet Pharmacol Ther; 2008 Oct; 31(5):423-30. PubMed ID: 19000261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single- and repeat-dose pharmacokinetic studies of chloramphenicol in horses: values and limitations of pharmacokinetic studies in predicting dosage regimens.
    Varma KJ; Powers TE; Powers JD
    Am J Vet Res; 1987 Mar; 48(3):403-6. PubMed ID: 3565895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parabolic quantitative structure-activity relationships and photodynamic therapy: application of a three-compartment model with clearance to the in vivo quantitative structure-activity relationships of a congeneric series of pyropheophorbide derivatives used as photosensitizers for photodynamic therapy.
    Potter WR; Henderson BW; Bellnier DA; Pandey RK; Vaughan LA; Weishaupt KR; Dougherty TJ
    Photochem Photobiol; 1999 Nov; 70(5):781-8. PubMed ID: 10568170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elimination of native and carbohydrate-modified tissue plasminogen activator in rabbits.
    Einarsson M; Hggroth L; Mattsson C
    Thromb Haemost; 1989 Dec; 62(4):1088-93. PubMed ID: 2515604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of single doses of cefoperazone given by the intravenous and intramuscular routes to unweaned calves.
    Soback S; Ziv G
    Res Vet Sci; 1989 Sep; 47(2):158-63. PubMed ID: 2799072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of propylthiouracil upon p.o. administration in man.
    Ringhand HP; Ritschel WA; Meyer MC; Straughn AB; Hardt T
    Int J Clin Pharmacol Ther Toxicol; 1980 Nov; 18(11):488-93. PubMed ID: 7203724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iterative least-squares fitting programs in pharmacokinetics for a programmable handheld calculator.
    Messori A; Donati-Cori G; Tendi E
    Am J Hosp Pharm; 1983 Oct; 40(10):1673-84. PubMed ID: 6688925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacokinetic study of the neuroleptic, azabutyrone].
    Gavlik I; Ianku I; Pochatov IuM; Raevskiĭ KS
    Farmakol Toksikol; 1976; 39(4):402-6. PubMed ID: 1027565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacodisposition of thiamphenicol in rabbits.
    Abd El-Aty AM; Abo El Sooud K; Goudah AM
    Dtsch Tierarztl Wochenschr; 2001 Sep; 108(9):393-6. PubMed ID: 11599443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and bioavailability of cefquinome in healthy piglets.
    Li XB; Wu WX; Su D; Wang ZJ; Jiang HY; Shen JZ
    J Vet Pharmacol Ther; 2008 Dec; 31(6):523-7. PubMed ID: 19000274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacokinetic studies of epervudine in rats using HPLC].
    Dereszlay I; Mészáros S; Csárdi A; Pátfalusi M; Vereczkey L
    Acta Pharm Hung; 1993 Jul; 63(4):227-36. PubMed ID: 8379339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Slow clearance of acylated, hybrid thrombolytic enzymes.
    Robinson JH; Dodd I; Esmail A; Ferres H; Nunn B
    Thromb Haemost; 1988 Jun; 59(3):421-5. PubMed ID: 3187931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functionalized carriers for the improved delivery of plasminogen activators.
    Vaidya B; Agrawal GP; Vyas SP
    Int J Pharm; 2012 Mar; 424(1-2):1-11. PubMed ID: 22222184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complicated simplification of dosage regimen for plasminogen activators.
    Maksimenko AV
    Ann N Y Acad Sci; 1996 Oct; 799():139-45. PubMed ID: 8958084
    [No Abstract]   [Full Text] [Related]  

  • 40. Concentration at steady-state after periodic and non-uniform administration of drug.
    Plusquellec Y; De Biasi J; Souhait J
    Eur J Pharm Biopharm; 1999 May; 47(3):305-7. PubMed ID: 10382117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.